Table 1.
Demographic Characteristics of Participants and Nonparticipants in the Mayo Clinic Study of Aging, 2004–2013
Characteristic | ACT Group (n = 1,730) |
PAS Group (n = 237) |
P Valuea | ACT + PAS Group (n = 1,967) |
REFUS Groupb (n = 1,301) |
P Valuec | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Median (IQRd) | No. | % | Median (IQR) | No. | % | Median (IQR) | No. | % | Median (IQR) | No. | % | |||
Age at enrollment visit or refusal/exclusion date, years |
80.1 (75.2–83.8) | 82.2 (76.7–85.3) | <0.0001 | 80.4 (75.4–84.0) | 81.6 (76.3–85.0) | <0.0001 | ||||||||
Female sex | 847 | 49.0 | 119 | 50.2 | 0.72 | 966 | 49.1 | 683 | 52.5 | 0.06 | ||||
Education, years | 13 (12.0–16.0) | 12 (12.0–15.0) | 0.015 | 13 (12.0–16.0) | 12 (11.0–14.0) | <0.0001 | ||||||||
≤12 years of education | 782 | 45.2 | 126 | 53.2 | 0.021 | 908 | 46.2 | 827 | 63.6 | <0.0001 | ||||
Charlson comorbidity index score |
3 (2.0–6.0) | 4 (2.0–6.0) | 0.019 | 4 (2.0–6.0) | 3 (1.0–6.0) | <0.0001 | ||||||||
Years from enrollment or first contact to dementia or censoringe |
6.2 (4.2–6.6) | 2.9 (1.2–3.8) | <0.0001 | 5.2 (3.6–6.6) | 3.9 (2.9–4.5) | <0.0001 | ||||||||
Incident dementia | 243 | 19 | 262 | 152 | ||||||||||
Alzheimer's disease | 175 | 77.1 | 12 | 63.2 | 0.02 | 187 | 76.0 | 111 | 74.0 | |||||
Vascular dementia | 19 | 8.4 | 6 | 31.6 | 25 | 10.2 | 25 | 16.7 | ||||||
Dementia with Lewy bodies | 15 | 6.6 | 1 | 5.3 | 16 | 6.5 | 14 | 9.3 | ||||||
Frontotemporal dementia | 3 | 1.3 | 0 | 0.0 | 3 | 1.2 | 0 | 0.0 | ||||||
Other | 15 | 6.6 | 0 | 0.0 | 15 | 6.1 | 0 | 0.0 |
Abbreviations: ACT, active surveillance; IQR, interquartile range; PAS, passive surveillance; REFUS, refusal.
a P value for comparison of the ACT group with the PAS group.
b The subset of nonparticipants who refused any participation. Incident dementia in the REFUS group was determined entirely by medical record review.
c P value for comparison of the ACT + PAS group with the REFUS group.
d 25th–75th percentiles.
e Censoring events were death, medical record review, or the end of the observation period (September 15, 2013), depending upon the subject group.